Cannabidiol and Other Cannabinoids in Demyelinating Diseases

por Navarrete, Carmen, García-Martín, Adela, Rolland, Alain, DeMesa, Jim, Muñoz, Eduardo
Publicado 2021

Immunomodulatory and Inhibitory Effect of Immulina(®), and Immunloges(®) in the Ig-E Mediated Activation of RBL-2H3 Cells. A New Role in Allergic Inflammatory Responses

por Appel, Kurt, Munoz, Eduardo, Navarrete, Carmen, Cruz-Teno, Cristina, Biller, Andreas, Thiemann, Eva
Publicado 2018

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis

por Carrillo-Salinas, Francisco J., Navarrete, Carmen, Mecha, Miriam, Feliú, Ana, Collado, Juan A., Cantarero, Irene, Bellido, María L., Muñoz, Eduardo, Guaza, Carmen
Publicado 2014

A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury

por Navarrete, Carmen, García-Martín, Adela, Correa-Sáez, Alejandro, Prados, María E., Fernández, Francisco, Pineda, Rafael, Mazzone, Massimiliano, Álvarez-Benito, Marina, Calzado, Marco A., Muñoz, Eduardo
Publicado 2022

Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration

por Aguareles, José, Paraíso-Luna, Juan, Palomares, Belén, Bajo-Grañeras, Raquel, Navarrete, Carmen, Ruiz-Calvo, Andrea, García-Rincón, Daniel, García-Taboada, Elena, Guzmán, Manuel, Muñoz, Eduardo, Galve-Roperh, Ismael
Publicado 2019

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathwa...

por del Río, Carmen, Navarrete, Carmen, Collado, Juan A., Bellido, M. Luz, Gómez-Cañas, María, Pazos, M. Ruth, Fernández-Ruiz, Javier, Pollastro, Federica, Appendino, Giovanni, Calzado, Marco A., Cantarero, Irene, Muñoz, Eduardo
Publicado 2016

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

por Navarrete, Carmen, Carrillo-Salinas, Francisco, Palomares, Belén, Mecha, Miriam, Jiménez-Jiménez, Carla, Mestre, Leyre, Feliú, Ana, Bellido, Maria L., Fiebich, Bernd L., Appendino, Giovanni, Calzado, Marco A., Guaza, Carmen, Muñoz, Eduardo
Publicado 2018

Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives

por Götz, Marcus R., Collado, Juan A., Fernández-Ruiz, Javier, Fiebich, Bernd L., García-Toscano, Laura, Gómez-Cañas, María, Koch, Oskar, Leha, Andreas, Muñoz, Eduardo, Navarrete, Carmen, Pazos, Maria R., Holzgrabe, Ulrike
Publicado 2019

VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity

por Palomares, Belen, Ruiz-Pino, Francisco, Navarrete, Carmen, Velasco, Inmaculada, Sánchez-Garrido, Miguel A., Jimenez-Jimenez, Carla, Pavicic, Carolina, Vazquez, Maria J., Appendino, Giovanni, Bellido, M. Luz, Calzado, Marco A., Tena-Sempere, Manuel, Muñoz, Eduardo
Publicado 2018

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease

por Díaz-Alonso, Javier, Paraíso-Luna, Juan, Navarrete, Carmen, del Río, Carmen, Cantarero, Irene, Palomares, Belén, Aguareles, José, Fernández-Ruiz, Javier, Bellido, María Luz, Pollastro, Federica, Appendino, Giovanni, Calzado, Marco A., Galve-Roperh, Ismael, Muñoz, Eduardo
Publicado 2016

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different...

por García, Concepción, Gómez-Cañas, María, Burgaz, Sonia, Palomares, Belén, Gómez-Gálvez, Yolanda, Palomo-Garo, Cristina, Campo, Sara, Ferrer-Hernández, Joel, Pavicic, Carolina, Navarrete, Carmen, Luz Bellido, M., García-Arencibia, Moisés, Ruth Pazos, M., Muñoz, Eduardo, Fernández-Ruiz, Javier
Publicado 2018

Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency

por Ogishi, Masato, Arias, Andrés Augusto, Yang, Rui, Han, Ji Eun, Zhang, Peng, Rinchai, Darawan, Halpern, Joshua, Mulwa, Jeanette, Keating, Narelle, Chrabieh, Maya, Lainé, Candice, Seeleuthner, Yoann, Ramírez-Alejo, Noé, Nekooie-Marnany, Nioosha, Guennoun, Andrea, Muller-Fleckenstein, Ingrid, Fleckenstein, Bernhard, Kilic, Sara S., Minegishi, Yoshiyuki, Ehl, Stephan, Kaiser-Labusch, Petra, Kendir-Demirkol, Yasemin, Rozenberg, Flore, Errami, Abderrahmane, Zhang, Shen-Ying, Zhang, Qian, Bohlen, Jonathan, Philippot, Quentin, Puel, Anne, Jouanguy, Emmanuelle, Pourmoghaddas, Zahra, Bakhtiar, Shahrzad, Willasch, Andre M., Horneff, Gerd, Llanora, Genevieve, Shek, Lynette P., Chai, Louis Y.A., Tay, Sen Hee, Rahimi, Hamid H., Mahdaviani, Seyed Alireza, Nepesov, Serdar, Bousfiha, Aziz A., Erdeniz, Emine Hafize, Karbuz, Adem, Marr, Nico, Navarrete, Carmen, Adeli, Mehdi, Hammarstrom, Lennart, Abolhassani, Hassan, Parvaneh, Nima, Al Muhsen, Saleh, Alosaimi, Mohammed F., Alsohime, Fahad, Nourizadeh, Maryam, Moin, Mostafa, Arnaout, Rand, Alshareef, Saad, El-Baghdadi, Jamila, Genel, Ferah, Sherkat, Roya, Kiykim, Ayça, Yücel, Esra, Keles, Sevgi, Bustamante, Jacinta, Abel, Laurent, Casanova, Jean-Laurent, Boisson-Dupuis, Stéphanie
Publicado 2022